News Agency
Men's Weekly

Ractigen Therapeutics Announces China NMPA IND Approval for Phase II Clinical Trial of saRNA Therapy RAG-01 in Non-Muscle Invasive Bladder Cancer

  • Written by PR Newswire

NANTONG, China, March 19, 2026 /PRNewswire/ -- Ractigen Therapeutics, a pioneering clinical-stage biotechnology company developing innovative small activating RNA (saRNA) therapeutics, today announced that China's National Medical Products Administration (NMPA) Center for Drug Evaluation (CDE) has approved its Investigational New Drug (IND)...

Read more: Ractigen Therapeutics Announces China NMPA IND Approval for Phase II Clinical Trial of saRNA...

Commercial Construction Companies Melbourne And Building The City’s Business Backbone

Commercial construction companies in Melbourne play a defining role in shaping how the city works, grows, and functions. From office buildings and retail spaces to industrial facilities and mixed-use developments, these companies are responsible for creating environments where businesses operate and... Read more

Writers Wanted



NewsServices.com

Content & Technology Connecting Global Audiences

More Information - Less Opinion